View Post

Immunotherapy Expands Treatment Options for Metastatic Bladder Cancer

In Clinical Trials by Barbara Jacoby

By: Danielle Ternyila From: Several recent updates from clinical trials are transforming the treatment landscape for urothelial carcinoma across a variety of subtypes. The use of immunotherapy, in particular, provides patients who progress after standard platinum-based chemotherapy with new hope and a plethora of options. In the metastatic setting, there have been 5 immune checkpoint inhibitors approved by the …